A novel approach for prevention and dissolution of cholesterol gallstones

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Liver international (Print)

• Publication date

  2008-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1478-3231.2008.01812.xPMID 18783538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ezetimibe prevents cholesterol gallstone formation in mice

  2008cited by this paper
• Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.

  2008cited by this paper
• Liver X receptor and farnesoid X receptor as therapeutic targets.

  2007cited by this paper
• Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.

  2007influential reference
• Ezetimibe ameliorates cholecystosteatosis.

  2007cited by this paper
• Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization

  2007cited by this paper
• Cholesterol gallstone disease.

  2006influential reference
• New insights into the genetic regulation of intestinal cholesterol absorption.

  2005cited by this paper
• Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.

  2004cited by this paper
• Enterohepatic bile salt transporters in normal physiology and liver disease.

  2004cited by this paper
• Treatment of High-Risk patients with ezetimibe plus simvastatin Co-Administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III Low-Density lipoprotein cholesterol goals

  2004cited by this paper
• Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.

  2004cited by this paper
• Identification of a nuclear receptor for bile acids.

  1999cited by this paper
• Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile.

  1997cited by this paper
• Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences.

  1996cited by this paper
• Ursodeoxycholic acid treatment of cholesterol gallstone disease.

  1994cited by this paper
• The physicochemical basis of cholesterol gallstone formation in man.

  1968cited by this paper

• Association between hereditary spherocytosis and gallstone disease: Pathophysiology, diagnosis, and management

  2025cites this paper
• The potential bidirectional association between Helicobacter pylori infection and gallstone disease in adults: A two‐cohort study

  2022cites this paper
• CONSERVATIVE VS LAPAROSCOPIC CHOLECYSTECTOMY IN RELATION TO THE SIZE & NUMBER OF GALL BLADDER STONES AND ASSOCIATED FACTORS AFFECTING DECISION-MAKING

  2019cites this paper
• Helicobacter Pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta‐analysis

  2018cites this paper
• Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation?

  2010cites this paper
• Updates in the treatment of gallstones

  2009cites this paper